A detailed history of West End Advisors, LLC transactions in Danaher Corp stock. As of the latest transaction made, West End Advisors, LLC holds 7 shares of DHR stock, worth $1,645. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7
Previous 8 12.5%
Holding current value
$1,645
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$239.25 - $280.76 $239 - $280
-1 Reduced 12.5%
7 $1,000
Q2 2024

Jul 29, 2024

SELL
$235.51 - $267.98 $471 - $535
-2 Reduced 20.0%
8 $1,000
Q4 2023

Jan 18, 2024

BUY
$185.1 - $233.13 $185 - $233
1 Added 11.11%
10 $2,000
Q3 2023

Oct 19, 2023

BUY
$233.08 - $265.59 $2,097 - $2,390
9 New
9 $2,000
Q2 2022

Jul 28, 2022

BUY
$237.11 - $299.66 $474 - $599
2 Added 33.33%
8 $2.03 Million
Q1 2022

Apr 26, 2022

BUY
$257.27 - $315.76 $257 - $315
1 Added 20.0%
6 $1.76 Million
Q2 2021

Jul 15, 2021

BUY
$225.08 - $271.69 $1,125 - $1,358
5 New
5 $1.34 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $171B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track West End Advisors, LLC Portfolio

Follow West End Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West End Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on West End Advisors, LLC with notifications on news.